115 related articles for article (PubMed ID: 8759721)
21. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids.
Wang F; Sengupta TK; Zhong Z; Ivashkiv LB
J Exp Med; 1995 Dec; 182(6):1825-31. PubMed ID: 7500028
[TBL] [Abstract][Full Text] [Related]
22. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling.
Teague TK; Schaefer BC; Hildeman D; Bender J; Mitchell T; Kappler JW; Marrack P
J Exp Med; 2000 Mar; 191(6):915-26. PubMed ID: 10727454
[TBL] [Abstract][Full Text] [Related]
23. CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells.
Mahajan S; Gollob JA; Ritz J; Frank DA
Exp Hematol; 2001 Feb; 29(2):209-20. PubMed ID: 11166460
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of IFN-gamma signaling by glucocorticoids.
Hu X; Li WP; Meng C; Ivashkiv LB
J Immunol; 2003 May; 170(9):4833-9. PubMed ID: 12707366
[TBL] [Abstract][Full Text] [Related]
25. Cell proliferation and STAT6 pathways are negatively regulated in T cells by STAT1 and suppressors of cytokine signaling.
Yu CR; Mahdi RM; Ebong S; Vistica BP; Chen J; Guo Y; Gery I; Egwuagu CE
J Immunol; 2004 Jul; 173(2):737-46. PubMed ID: 15240659
[TBL] [Abstract][Full Text] [Related]
26. [The Na,K-ATPase pump and blast transformation of human peripheral blood lymphocytes].
Marakhova II; Vinogradova TA; Toropova FV
Tsitologiia; 1995; 37(12):1167-79. PubMed ID: 8714352
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of Stat1-mediated gene activation by PIAS1.
Liu B; Liao J; Rao X; Kushner SA; Chung CD; Chang DD; Shuai K
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10626-31. PubMed ID: 9724754
[TBL] [Abstract][Full Text] [Related]
28. Rebuilding the balance of STAT1 and STAT3 signalings by fusaruside, a cerebroside compound, for the treatment of T-cell-mediated fulminant hepatitis in mice.
Wu XX; Sun Y; Guo WJ; Gu YH; Wu XF; Tan RX; Xu Q
Biochem Pharmacol; 2012 Nov; 84(9):1164-73. PubMed ID: 22902832
[TBL] [Abstract][Full Text] [Related]
29. Human T
Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
[TBL] [Abstract][Full Text] [Related]
30. Expression of 5HT1a receptors on activated human T cells. Regulation of cyclic AMP levels and T cell proliferation by 5-hydroxytryptamine.
Aune TM; McGrath KM; Sarr T; Bombara MP; Kelley KA
J Immunol; 1993 Aug; 151(3):1175-83. PubMed ID: 8393041
[TBL] [Abstract][Full Text] [Related]
31. IGF-1 down-regulates IFN-gamma R2 chain surface expression and desensitizes IFN-gamma/STAT-1 signaling in human T lymphocytes.
Bernabei P; Bosticardo M; Losana G; Regis G; Di Paola F; De Angelis S; Giovarelli M; Novelli F
Blood; 2003 Oct; 102(8):2933-9. PubMed ID: 12842994
[TBL] [Abstract][Full Text] [Related]
32. Vitamin D pathway activation selectively deactivates signal transducer and activator of transcription (STAT) proteins and inflammatory cytokine production in natural killer leukemic large granular lymphocytes.
Olson KC; Kulling Larkin PM; Signorelli R; Hamele CE; Olson TL; Conaway MR; Feith DJ; Loughran TP
Cytokine; 2018 Nov; 111():551-562. PubMed ID: 30455079
[TBL] [Abstract][Full Text] [Related]
33. Selective activation of signal transducer and activator of transcription (STAT) proteins STAT1 and STAT3 in human endothelial cells infected with Rickettsia rickettsii.
Sahni SK; Kiriakidi S; Colonne MP; Sahni A; Silverman DJ
Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():303-4. PubMed ID: 19438651
[No Abstract] [Full Text] [Related]
34. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.
Grandis JR; Drenning SD; Chakraborty A; Zhou MY; Zeng Q; Pitt AS; Tweardy DJ
J Clin Invest; 1998 Oct; 102(7):1385-92. PubMed ID: 9769331
[TBL] [Abstract][Full Text] [Related]
35. STAT1 activation during monocyte to macrophage maturation: role of adhesion molecules.
Coccia EM; Del Russo N; Stellacci E; Testa U; Marziali G; Battistini A
Int Immunol; 1999 Jul; 11(7):1075-83. PubMed ID: 10383940
[TBL] [Abstract][Full Text] [Related]
36. Modulation of STAT signaling by STAT-interacting proteins.
Shuai K
Oncogene; 2000 May; 19(21):2638-44. PubMed ID: 10851063
[TBL] [Abstract][Full Text] [Related]
37. Lipopolysaccharide-mediated modulation of cytochromes P450 in Stat1 null mice.
Pan J; Xiang Q; Ball S; Scatina J; Kao J; Hong JY
Drug Metab Dispos; 2003 Apr; 31(4):392-7. PubMed ID: 12642464
[TBL] [Abstract][Full Text] [Related]
38. The effects of cAMP on the expression of glycolytic isozymes in activated peripheral human T lymphocytes.
Marjanovic S; Wollberg P; Skog S; Heiden T; Nelson BD
Arch Biochem Biophys; 1993 May; 302(2):398-401. PubMed ID: 8387745
[TBL] [Abstract][Full Text] [Related]
39. Elevated level of interleukin-35 in colorectal cancer induces conversion of T cells into iTr35 by activating STAT1/STAT3.
Ma Y; Chen L; Xie G; Zhou Y; Yue C; Yuan X; Zheng Y; Wang W; Deng L; Shen L
Oncotarget; 2016 Nov; 7(45):73003-73015. PubMed ID: 27682874
[TBL] [Abstract][Full Text] [Related]
40. Correlation between pretreatment levels of interferon response genes and clinical responses to an immune response modifier (Imiquimod) in genital warts.
Arany I; Tyring SK; Brysk MM; Stanley MA; Tomai MA; Miller RL; Smith MH; McDermott DJ; Slade HB
Antimicrob Agents Chemother; 2000 Jul; 44(7):1869-73. PubMed ID: 10858346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
